Corcept Therapeutics Incorporated · NASDAQ:CORT

Robb Gary Charles received 1,552 Corcept Therapeutics Incorporated shares as an award (Form 4)

Traded Jun 1 to Jun 2, 2026 · Filed Jun 3, 2026

From Jun 1 to Jun 2, 2026, Robb Gary Charles (Chief Business Officer) received 1,552 Corcept Therapeutics Incorporated shares as an award at US$70.44 for US$54,661, leaving 25,681 shares. Filed Jun 3, 2026 (Form 4).

Awarded
1,552 shares
Price
US$70.44
Value
US$54,661
Holding after
25,681 shares
Trading plan
No
Role
Chief Business Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockAward776US$70.4425,263Direct
Jun 1, 2026Common StockAward77626,039Direct
Jun 2, 2026Common StockShares withheld for tax358US$70.4425,681Direct

Source

View original at SEC

Related